A Therapy Treatment Response Trial in Patients With Leptomeningeal Metastases ((LM) Using CNSide
Conditions:   Leptomeningeal Metastasis;   Leptomeningeal Disease;   Leptomeningeal Neoplasms;   Breast Cancer;   Non-Small Cell Lung Cancer Intervention:   Device: CNSide Sponsors:   Biocept, Inc.;   ICON plc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 10, 2022 Category: Research Source Type: clinical trials

Study of TY-9591 in Patients With a Lung Cancer With Brain or Leptomeningeal Metastases With EGFR Mutation
Conditions:   NSCLC;   EGFR Activating Mutation;   Brain Metastases;   Leptomeningeal Metastasis Intervention:   Drug: TY-9591 Tablets Sponsor:   TYK Medicines, Inc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2021 Category: Research Source Type: clinical trials